Reverse transcriptase activity of hepatitis B virus polymerase in eukaryotic cell extracts in vitro

Altex

Volumn 25, Issue 3, 2008, Pages 197-211

  Favre, Daniel ^a  

^a Helpatitis   (Switzerland)

Author keywords

Cell extract; HBV; Hepatitis B virus; Hepatocyte; HuH 7; Inhibitors; Reverse transcriptase; Reverse transcription; RNA; Translation; Viral polymerase

Indexed keywords

CELL EXTRACT; COMPLEMENTARY DNA; LAMIVUDINE; MESSENGER RNA; RNA DIRECTED DNA POLYMERASE; DNA DIRECTED DNA POLYMERASE; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL TESTING ALTERNATIVE; ANTIVIRAL ACTIVITY; ARTICLE; CELL STRAIN BHK; CHICKEN; CONTROLLED STUDY; ENZYME ACTIVE SITE; ENZYME ACTIVITY; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IN VITRO SELECTION; LIVER CELL CULTURE; NONHUMAN; RABBIT; RETICULOCYTE LYSATE; REVERSE TRANSCRIPTION; ANIMAL; CELL LINE; EUKARYOTIC CELL; GENE EXPRESSION REGULATION; HAMSTER; LIVER CELL; METABOLISM; PHYSIOLOGY; PLASMID;

ANIMALS; CELL LINE; CHICKENS; CRICETINAE; DNA-DIRECTED DNA POLYMERASE; EUKARYOTIC CELLS; GENE EXPRESSION REGULATION, VIRAL; HEPATITIS B VIRUS; HEPATOCYTES; HUMANS; PLASMIDS; RNA-DIRECTED DNA POLYMERASE; VIRAL NONSTRUCTURAL PROTEINS;

EID: 58949088172     PISSN: 09467785     EISSN: None     Source Type: Journal    
DOI: 10.14573/altex.2008.3.197     Document Type: Article

References (61)

1. Addison, W. R., Walters, K. A., Wong, W. W. et al. (2002). Half-life of the duck hepatitis B virus covalently closed circular DNA pool in vivo following inhibition of viral replication. J. Virol. 76, 6356-6363. (Pubitemid 34556330)
2. Aguesse-Germon, S., Liu, S. H., Chevallier, M. et al. (1998). Inhibitory effect of 2′-fluoro-5-methyl-beta-L-arabinofuranosyl-uracil on duck hepatitis B virus replication. Antimicrob. Agents Chemother. 42, 369-376.
3. Barry, J. K. and Miller, W. A. (2002). A -1 ribosomal frameshift element that requires base pairing across four kilobases suggests a mechanism of regulating ribosome and replicase traffic on a viral RNA. Proc. Natl. Acad. Sci. U S A 99, 11133-11138. (Pubitemid 34920891)
4. Beck, J. and Nassal, M. (1998). Formation of a functional hepatitis B virus replication initiation complex involves a major structural alteration in the RNA template. Mol. Cell. Biol. 18, 6265-6272. (Pubitemid 28500517)
5. Cao, F. and Tavis, J. E. (2006). Suppression of mRNA accumulation by the duck hepatitis B virus reverse transcriptase. Virology 350, 475-483. (Pubitemid 43928111)
6. Cavanaugh, V. J., Guidotti, L. G. and Chisari, F. V. (1997). Interleukin-12 inhibits hepatitis B virus replication in transgenic mice. J. Virol. 71, 3236-3243.
7. Chang, L. J., Pryciak, P., Ganem, D. and Varmus, H. E. (1989). Biosynthesis of the reverse transcriptase of hepatitis B viruses involves de novo translational initiation not ribosomal frameshifting. Nature 337, 364-368. (Pubitemid 19043499)
8. Colledge, D., Locarnini, S. and Shaw, T. (1997). Synergistic inhibition of hepadnaviral replication by lamivudine in combination with penciclovir in vitro. Hepatology 26, 216-225. (Pubitemid 27280328)
9. Cullen, J. M., Smith, S. L., Davis, M. G. et al. (1997). In vivo antiviral activity and pharmacokinetics of (-)-cis-5-fluoro-1- [2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine in woodchuck hepatitis virus-infected woodchucks. Antimicrob. Agents Chemother. 41, 2076-2082. (Pubitemid 27422193)
10. Doong, S. L., Tsai, C. H., Schinazi, R. F. et al. (1991). Inhibition of the replication of hepatitis B virus in vitro by 2′,3′- dideoxy-3′-thiacytidine and related analogues. Proc. Natl. Acad. Sci. U S A 88, 8495-8499. (Pubitemid 21915383)
11. Favre, D., Berthillon, P. and Trépo, C. (2001). Removal of cell-bound lipoproteins: a crucial step for the efficient infection of liver cells with hepatitis C virus in vitro. C. R. Acad. Sci. 324, 1141-1148. (Pubitemid 34026770)
12. Favre, D. and Muellhaupt, B. (2005). Reactivation of creatine kinase by dithiothreitol prior to use in an in vitro translation extract. ALTEX 22, 259-264. (Pubitemid 43056475)
13. Favre, D., Petit, M. A. and Trépo, C. (2003). Latent hepatitis B virus (HBV) infection and HBV DNA integration is associated with further transformation of hepatoma cells in vitro. ALTEX 20, 131-142.
14. Favre, D. and Trépo, C. (2001). Translational extracts active biologically in vitro obtained from eukaryotic monolayer cells: a versatile method for viral RNA studies. J. Virol. Methods 92, 177-181. (Pubitemid 32171985)
15. Fourel, D., Bernadac, A. and Pages, J. M. (1994). Involvement of exposed polypeptide loops in trimeric stability and membrane insertion of Escherichia coli OmpF porin. Eur. J. Biochem. 222, 625-630. (Pubitemid 24204935)
16. Gaillard, R. K., Barnard, J., Lopez, V. et al. (2002). Kinetic analysis of wildtype and YMDD mutant hepatitis B virus polymerases and effects of deoxyribonucleotide concentrations on polymerase activity. Antimicrob. Agents Chemother. 46, 1005-1013.
17. Genovesi, E. V., Lamb, L., Medina, I. et al. (2000). Antiviral efficacy of lobucavir (BMS-180194), a cyclobutylguanosine nucleoside analogue, in the woodchuck (Marmota monax) model of chronic hepatitis B virus (HBV) infection. Antiviral. Res. 48, 197-203.
18. Guo, Q., Zhao, L., You, Q. et al. (2007). Anti-hepatitis B virus activity of wogonin in vitro and in vivo. Antiviral Res. 74, 16-24. (Pubitemid 46366014)
19. Hafkemeyer, P., Keppler-Hafkemeyer, A., al Haya, M. A. et al. (1996). Inhibition of duck hepatitis B virus replication by 2′,3′-dideoxy- 3′-fluoroguanosine in vitro and in vivo. Antimicrob. Agents Chemother. 40, 792-794.
20. Herold, J. and Andino, R. (2001). Poliovirus RNA replication requires genome circularization through a protein-protein bridge. Mol. Cell 7, 581-591. (Pubitemid 32706350)
21. Howe, A. Y., Robins, M. J., Wilson, J. S. and Tyrrell, D. L. (1996). Selective inhibition of the reverse transcription of duck hepatitis B virus by binding of 2′,3′-dideoxyguanosine 5′-triphosphate to the viral polymerase. Hepatology 23, 87-96. (Pubitemid 126664260)
22. Hu, J. and Seeger, C. (1996). Expression and characterization of hepadnavirus reverse transcriptases. Methods Enzymol. 275, 195-208. (Pubitemid 26336923)
23. Jacquard, A. C., Brunelle, M. N., Pichoud, C. et al. (2006). In vitro characterization of the anti-hepatitis B virus activity and cross-resistance profile of 2′,3′-dideoxy-3′-fluoroguanosine. Antimicrob. Agents Chemother. 50, 955-961.
24. Jeong, J. H., Kwak, D. S., Rho, H. M. and Jung, G. (1996). The catalytic properties of human hepatitis B virus polymerase. Biochem. Biophys. Res. Commun. 223, 264-271. (Pubitemid 26245556)
25. Kim, Y. and Jung, G. (1999). Active human hepatitis B viral polymerase expressed in rabbit reticulocyte lysate system. Virus Genes 19, 123-130. (Pubitemid 29469079)
26. Lanford, R. E., Notvall, L., Lee, H. and Beames, B. (1997). Transcomplementation of nucleotide priming and reverse transcription between independently expressed TP and RT domains of the hepatitis B virus reverse transcriptase. J. Virol. 71, 2996-3004. (Pubitemid 27119943)
27. Le Guerhier, F., Pichoud, C., Jamard, C. et al. (2001). Antiviral activity of beta-L-2′,3′-dideoxy-2′,3′-didehydro-5- fluorocytidine in woodchucks chronically infected with woodchuck hepatitis virus. Antimicrob. Agents Chemother. 45, 1065-1077. (Pubitemid 32230984)
28. Li, Z. and Tyrrell, D. L. (1999). Expression of an enzymatically active polymerase of human hepatitis B virus in an coupled transcription-translation system. Biochem. Cell Biol. 77, 119-126. (Pubitemid 29408968)
29. Lin, E., Luscombe, C., Colledge, D. et al. (1998). Long-term therapy with the guanine nucleoside analog penciclovir controls chronic duck hepatitis B virus infection in vivo. Antimicrob. Agents Chemother. 42, 2132-2137.
30. Lofgren, B., Vickery, K., Zhang, Y. Y. and Nordenfelt, E. (1996). 2′,3′-dideoxy-3′-fluoroguanosine inhibits duck hepatitis B virus in vivo. J. Viral Hepat. 3, 61-65. (Pubitemid 126734185)
31. Luscombe, C., Pedersen, J., Uren, E. and Locarnini, S. (1996). Long-term ganciclovir chemotherapy for congenital duck hepatitis B virus infection in vivo: effect on intrahepatic-viral DNA, RNA, and protein expression. Hepatology 24, 766-773. (Pubitemid 26334271)
32. Nakabayashi, H., Taketa, K., Miyano, K. et al. (1982). Growth of human hepatoma cell lines with differentiated functions in chemically defined medium. Cancer Research 42, 3858-3863. (Pubitemid 12054507)
33. Nassal, M. and Rieger, A. (1996). A bulged region of the hepatitis B virus RNA encapsidation signal contains the replication origin for discontinuous first-strand DNA synthesis. J. Virol. 70, 2764-2773. (Pubitemid 26121890)
34. Nicoll, A., Locarnini, S., Chou, S. T. et al. (2000). Effect of nucleoside analogue therapy on duck hepatitis B viral replication in hepatocytes and bile duct epithelial cells in vivo. J. Gastroenterol. Hepatol. 15, 304-310. (Pubitemid 30190746)
35. Nicoll, A. J., Colledge, D. L., Toole, J. J. et al. (1998). Inhibition of duck hepatitis B virus replication by 9-(2- phosphonylmethoxyethyl)adenine, an acyclic phosphonate nucleoside analogue. Antimicrob. Agents Chemother. 42, 3130-3135. (Pubitemid 28553730)
36. Ochoa, S. and de Haro, C. (1979). Regulation of protein synthesis in eukaryotes. Annu. Rev. Biochem. 48, 549-580.
37. Offensperger, W. B., Offensperger, S., Walter, E. et al. (1993a). Suramin prevents duck hepatitis B virus infection in vivo. Antimicrob. Agents Chemother. 37, 1539-1542. (Pubitemid 23202387)
38. Offensperger, W. B., Offensperger, S., Walter, E. et al. (1993b). In vivo inhibition of duck hepatitis B virus replication and gene expression by phosphorothioate modified antisense oligodeoxynucleotides. Embo J. 12, 1257-1262. (Pubitemid 23095875)
39. Pelham, H. R. and Jackson, R. J. (1976). An efficient mRNA-dependent translation system from reticulocyte lysates. Eur. J. Biochem. 67, 247-256.
40. Poch, O., Sauvaget, I., Delarue, M. and Tordo, N. (1989). Identification of four conserved motifs among the RNA-dependent polymerase encoding elements. Embo J. 8, 3867-3874. (Pubitemid 20016069)
41. Rahn, J. J., Kieller, D. M., Tyrrell, D. L. and Gati, W. P. (1997). Modulation of the metabolism of beta-L-(-)-2′,3′-dideoxy-3′- thiacytidine by thymidine, fludarabine, and nitrobenzylthioinosine. Antimicrob. Agents Chemother. 47, 918-923. (Pubitemid 27194160)
42. Rajagopalan, P., Boudinot, F. D., Chu, C. K. et al. (1996). Pharmacokinetics of (-)-2′-3′-dideoxy-3′-thiacytidine in woodchucks. Antimicrob. Agents Chemother. 40, 642-645. (Pubitemid 126507342)
43. Robaczewska, M., Narayan, R., Seigneres, B. et al. (2005). Sequence-specific inhibition of duck hepatitis B virus reverse transcription by peptide nucleic acids (PNA). J. Hepatol. 42, 180-187.
44. Roychoudhury, S., Faruqi, A. F. and Shih, C. (1991). Pregenomic RNA encapsidation analysis of eleven missense and nonsense polymerase mutants of human hepatitis B virus. J. Virol. 65, 3617-3624.
45. Seifer, M., Hamatake, R. K., Colonno, R. J. and Standring, D. N. (1998). In vitro inhibition of hepadnavirus polymerases by the triphosphates of BMS-200475 and lobucavir. Antimicrob. Agents Chemother. 42, 3200-3208. (Pubitemid 28553742)
46. Seifer, M. and Standring, D. N. (1993). Recombinant human hepatitis B virus reverse transcriptase is active in the absence of the nucleocapsid or the viral replication origin, DR1. J. Virol. 67, 4513-4520. (Pubitemid 23215929)
47. Seigneres, B., Aguesse-Germon, S., Pichoud, C. et al. (2001). Duck hepatitis B virus polymerase gene mutants associated with resistance to lamivudine have a decreased replication capacity in vitro and in vivo. J. Hepatol. 34, 114-122.
48. Seigneres, B., Martin, P., Werle, B. et al. (2003). Effects of pyrimidine and purine analog combinations in the duck hepatitis B virus infection model. Antimicrob. Agents Chemother. 47, 1842-1852. (Pubitemid 36637804)
49. Seigneres, B., Pichoud, C., Ahmed, S. S. et al. (2000). Evolution of hepatitis B virus polymerase gene sequence during famciclovir therapy for chronic hepatitis B. J. Infect Dis. 181, 1221-1233. (Pubitemid 30252525)
50. Severini, A., Liu, X. Y., Wilson, J. S. and Tyrrell, D. L. (1995). Mechanism of inhibition of duck hepatitis B virus polymerase by (-)- beta-L-2′,3′-dideoxy-3′-thiacytidine. Antimicrob. Agents Chemother. 39, 1430-1435.
51. Shaw, T., Mok, S. S. and Locarnini, S. A. (1996). Inhibition of hepatitis B virus DNA polymerase by enantiomers of penciclovir triphosphate and metabolic basis for selective inhibition of HBV replication by penciclovir. Hepatology 24, 996-1002. (Pubitemid 26365894)
52. Skup, D. and Millward, S. (1977). Highly efficient translation of messenger RNA in cell-free extracts prepared from L-cells. Nucleic Acids Res. 4, 3581-3587.
53. Svitkin, Y. V., Pause, A. and Sonenberg, N. (1994). La autoantigen alleviates translational repression by the 5′ leader sequence of the human immunodeficiency virus type 1 mRNA. J. Virol. 68, 7001-17001 (Pubitemid 24328750)
54. Tavis, J. E. and Ganem, D. (1993). Expression of functional hepatitis B virus polymerase in yeast reveals it to be the sole viral protein required for correct initiation of reverse transcription. Proc. Natl. Acad. Sci. U S A 90, 4107-4111. (Pubitemid 23134175)
55. Tavis, J. E., Perri, S. and Ganem, D. (1994). Hepadnavirus reverse transcription initiates within the stem-loop of the RNA packaging signal and employs a novel strand transfer. J. Virol. 68, 3536-3543. (Pubitemid 24177377)
56. Tomita, T., Yokosuka, O., Tagawa, M. et al. (2000). Decrease of wild-type and precore mutant duck hepatitis B virus replication during lamivudine treatment in white Pekin ducks infected with the viruses. J. Hepatol. 32, 850-858.
57. Urban, S., Fischer, K. P. and Tyrrell, D. L. (2001). Efficient pyrophosphorolysis by a hepatitis B virus polymerase may be a primer-unblocking mechanism. Proc. Natl. Acad. Sci. U S A 98, 4984-4989. (Pubitemid 32397069)
58. Wang, G. H. and Seeger, C. (1992). The reverse transcriptase of hepatitis B virus acts as a protein primer for viral DNA synthesis. Cell 71, 663-670.
59. Wang, W. L. (1992). [Expression and significance of Pre-S1 and Pre-S2 in human primary hepatic carcinoma (PHC)]. Zhonghua Zhong Liu Za Zhi 14, 83-86.
60. Witcher, J. W., Boudinot, F. D., Baldwin, B. H. et al. (1997). Pharmacokinetics of 1-(2-fluoro-5-methyl-beta-L-arabinofuranosyl)uracil in woodchucks. Antimicrob. Agents Chemother. 41, 2184-2187.
61. Zoulim, E, Dannaoui, E., Borel, C. et al. (1996). 2′,3′- dideoxy-beta-L-5-fluorocytidine inhibits duck hepatitis B virus reverse transcription and suppresses viral DNA synthesis in hepatocytes, both in vitro and in vivo. Antimicrob. Agents Chemother. 40, 448-453. (Pubitemid 26053143)